Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ASH2L | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
mRNA | C20orf202 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
mRNA | RHAG | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
mRNA | TSC22D1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
mRNA | PANK3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
mRNA | PHLDB2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
mRNA | NASP | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
mRNA | PUM2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
mRNA | PPP1R16B | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
mRNA | CYP7B1 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |